(29), CSF biomarkers (Aβ40, Aβ42, and phospho-Tau) and 123I-MIBG myocardial scintigraphy were used to confirm the clinical diagnosis in those participants who had progressed to MCI or dementia during the 7-year follow-up period. The gene discussed is MAPT; the disease is dementia.